RECRUITINGOBSERVATIONAL
Child-Parent Familial Hypercholesterolemia Screening
Child-Parent Screening of Familial Hypercholesterolemia in Children
About This Trial
Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scientific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.
Who May Be Eligible (Plain English)
Who May Qualify:
- Receive routine child care
- aged 1 - 3 years old ( date of investigate minus date of birth)
Who Should NOT Join This Trial:
- It is up to the researcher to decide whether it is suitable to participate in this research
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Receive routine child care
* aged 1 - 3 years old ( date of investigate minus date of birth)
Exclusion Criteria:
* It is up to the researcher to decide whether it is suitable to participate in this research
Treatments Being Tested
OTHER
no interventions
it is a observational study, do not have interventions.
Locations (6)
Anhui Provincial Children's Hospital
Hefei, Anhui, China
Qidong Women and Children Hospital
Qidong, Jiangsu, China
Weili Yan
Shanghai, Shanghai Municipality, China
Shanxi Provincial Children's Hospital
Taiyuan, Shanxi, China
Chongqin Medical University Affiliated Children's Hospital
Chongqing, Sichuan, China
Urumqi Children's Hospital
Ürümqi, Xinjiang, China